BusinessPuerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based ReliefBy Nasdaq OMXMar 26, 2018, 1:44 PM UTC
BusinessIndia Globalization Capital Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)By Nasdaq OMXMar 12, 2018, 12:01 PM UTC
BusinessIGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization StageBy Nasdaq OMXFeb 20, 2018, 2:14 PM UTC
BusinessIndia Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13By Nasdaq OMXFeb 12, 2018, 1:02 PM UTC
BusinessIndia Globalization's Hyalolex Shows Promise in Treating Patients with Alzheimer's Disease -- CFN MediaBy Nasdaq OMXFeb 8, 2018, 1:30 PM UTC
BusinessIndia Globalization Capital to use Blockchain to Address Issues Specific to the Medical Cannabis IndustryBy Nasdaq OMXDec 26, 2017, 1:00 PM UTC
BusinessIGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017By Nasdaq OMXDec 18, 2017, 1:00 PM UTC
BusinessIndia Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization StrategyBy Nasdaq OMXDec 14, 2017, 1:01 PM UTC